Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Bacillus Calmette-Guerin Vaccines
Research from K.E. Sharquie and co-researchers in the area of Bacillus calmette-guerin vaccines described
June 11th, 2008
New research, 'Bacille Calmette-Guerin immunotherapy of viral warts,' is the subject of a report. "To assess the effectiveness of the Bacille Calmette-Guerin BCG vaccine in the treatment of viral warts. A single blind placebo controlled study conducted at the Department of Dermatology, Baghdad Teaching Hospital, Baghdad, Iraq from March 2005 to June 2006," scientists writing in the Saudi Medical Journal report. "Two hundred patients with viral warts were enrolled in this study, and were fully assessed before therapy. The patients were divided into 2 equal matched groups. Group 1 was designed as the treatment group and received BCG vaccine in 1-3 doses with a...
Source: Vaccine Weekly (2008-06-11)
|
